New pill takes on deadly fungus in head-to-head trial
Disease control
Ongoing
This study tests a new oral drug, olorofim, against the standard treatment (AmBisome followed by other antifungals) for invasive aspergillosis, a serious fungal infection that mainly affects people with weak immune systems. About 225 adults will take part to see which approach re…
Phase: PHASE3 • Sponsor: F2G Biotech GmbH • Aim: Disease control
Last updated May 04, 2026 16:24 UTC